openPR Logo
Press release

Endocrine Testing Market - Positive long-term growth outlook 2023

05-22-2017 01:53 PM CET | Health & Medicine

Press release from: Transparency Market Research

Endocrine Testing Market

Endocrine Testing Market

The global endocrine testing market demonstrates a highly oligopolistic business structure with top 5 participants, namely F-Hoffmann La Roche, Abbott Laboratories, Agilent Technologies, DiaSorin, and Siemens Healthcare, holding almost 90% of the overall market share, finds Transparency Market Research. In 2014, Roche emerged as the leading market player with a share of 23.1%. The wide range of products, including lab automation systems, analyzers, next generation sequencing platforms, and endocrine test kits, offered by the company assisted it to reach this position.

At present, the market is facing stiff competition between its key players, which is likely to intensify in the near future. Companies will need to focus on expanding as well as advancing their portfolios in order to remain in the competition.

This 138 page report gives readers a comprehensive overview of the Endocrine Testing Market. Unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/endocrine-testing-market.html

“The rapid increase in the obese population, as well as the patient pool suffering from diabetes, has influenced the adoption of various endocrine testing technologies and services,” says an analyst at TMR. Diabetes is primarily caused due to the lack of insulin in the human body. As insulin regulates the blood sugar levels of the body, regular monitoring of this hormone is very important in order to control its excess or deficiency, which, if ignored, can cause a negative impact on health. This factor has widened the scope for management of diabetes across the world, thereby influencing the adoption of efficient endocrine testing methods and services.

Obesity, which has been arising as a major healthcare epidemic, worldwide, is also providing a huge ground to endocrine testing for applications as it leads to a number of chronic diseases such as cardiovascular disorders, stroke, hypertension, cancer, and various diseases related to reproductive system.

On the whole, the demand for endocrine testing looks steadily increasing in the near future. However, the high cost associated with it and the dearth of awareness regarding this technology in emerging nation may hinder its adoption to some extent over the forthcoming years.

Get accurate market forecast and analysis on the Endocrine Testing Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

As estimated by TMR, the worldwide opportunity in endocrine testing, which was worth US$6.1 bn in 2014, is likely to rise at a CAGR of 8.50% during the period from 2015 to 2023 and reach a value of US$12.8 bn by the end of the forecast period.

Currently, North America is the key contributor to the revenue generated in this market. The region is expected to remain at the leading position throughout the forecast period, accounting for a share of 38.3% by 2023. On the other hand, Asia Pacific is likely to report the fastest CAGR of 10.30% between 2015 and 2023.

Based on the test, the thyroid stimulating hormone segment exhibited a significant demand in 2014; however, insulin testing is projected to emerge as the fastest growing segment over the forecast period. Commercial laboratories have gained prominence as the key end user of endocrine testing techniques and immunoassay is the mostly applied technology in this testing across the world.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endocrine Testing Market - Positive long-term growth outlook 2023 here

News-ID: 545004 • Views:

More Releases from Transparency Market Research

Solar Micro Inverter Market to Reach USD 19.1 Bn by 2034, Driven by 15.5% CAGR Amid Rapid Residential Solar Adoption
Solar Micro Inverter Market to Reach USD 19.1 Bn by 2034, Driven by 15.5% CAGR A …
The global solar micro inverter market is entering a dynamic growth phase as renewable energy adoption accelerates worldwide. Valued at US$ 4.1 billion in 2023, the market is projected to expand at a robust CAGR of 15.5% from 2024 to 2034, reaching an estimated US$ 19.1 billion by the end of 2034. The rapid shift toward decentralized energy systems, technological innovation, and favorable government policies are positioning micro inverters as
SMT Equipment Market to Reach USD 9.1 Bn by 2031, Growing at 5.9% CAGR Amid Rising PCB Miniaturization
SMT Equipment Market to Reach USD 9.1 Bn by 2031, Growing at 5.9% CAGR Amid Risi …
The SMT Equipment Market is witnessing steady expansion driven by the rapid evolution of consumer electronics, automotive electronics, telecommunications infrastructure, industrial automation, and advanced computing systems. Surface Mount Technology (SMT) equipment is used in the manufacturing of printed circuit boards (PCBs) by mounting electronic components directly onto the surface of the boards. This technology has become the backbone of modern electronics production due to its efficiency, miniaturization capability, and cost-effectiveness. Explore
Bio-Based Flavors and Fragrances Market to Reach US$ 4.56 Billion by 2031, Driven by Natural Ingredients and Sustainable Cosmetic & Food Applications | Latest Report TMR
Bio-Based Flavors and Fragrances Market to Reach US$ 4.56 Billion by 2031, Drive …
The global bio-based flavors and fragrances market was valued at US$ 1,945.0 Million in 2021 and is projected to reach US$ 4,555.5 Million by 2031, growing at a CAGR of 8.3% from 2022 to 2031. This robust growth is driven by increasing consumer preference for natural and health-oriented ingredients, rising adoption of eco-friendly cosmetic and food products, and expanding applications in the pharmaceutical industry. Access key findings and insights from our
Breast Tissue Markers Market to Surpass USD 5.8 Billion by 2031, Driven by Rising Breast Cancer Incidence and Growth in Minimally Invasive Biopsy Procedures
Breast Tissue Markers Market to Surpass USD 5.8 Billion by 2031, Driven by Risin …
The global breast tissue markers market was valued at US$ 2.5 Bn in 2021 and is projected to expand at a CAGR of 8.3% from 2022 to 2031, reaching more than US$ 5.8 Bn by the end of 2031. The market is witnessing steady growth due to the rising incidence of breast cancer, increasing adoption of minimally invasive biopsy procedures, and advancements in diagnostic imaging technologies. Get Your Sample Report -

All 5 Releases


More Releases for Endocrine

Endocrine Testing: A Leading Driver Behind Impact of Diabetes Prevalence on Endo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Endocrine Testing Industry Market Size Be by 2025? In recent times, there has been a significant expansion in the size of the endocrine testing market. The market is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, reflecting a compound annual growth
Evolving Market Trends In The Endocrine Peptide Test Industry: Advancements in I …
The Endocrine Peptide Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Endocrine Peptide Test Market Size During the Forecast Period? The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to
Key Influencer in the Endocrine Testing Market 2025: Impact of Diabetes Prevalen …
What industry-specific factors are fueling the growth of the endocrine testing market? The growing prevalence of diabetes is also expected to drive the endocrine testing market. Similar to the peptide tests, endocrine testing is crucial for diagnosing, monitoring, and managing diabetes. As the disease becomes more prevalent, especially among younger populations, the demand for these diagnostic tests increases. According to NHS data from June 2024, diabetes diagnoses in individuals under 40
Key Influencer in the Endocrine Peptide Test Market 2025: Impact of Diabetes Pre …
What Is the Forecasted Market Size and Growth Rate for the Endocrine Peptide Test Market? The market size for endocrine peptide tests has significantly expanded in the recent past. The growth is slated to rise from $9.11 billion in 2024 to a significant $9.97 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.5%. The expansion during the historic phase is linked to factors like increased government
Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver: Leading …
"What Are the Projected Growth and Market Size Trends for the Endocrine Testing Market? In the past few years, the endocrine testing market has seen a significant expansion. The market, which is worth $2.55 billion in 2024, is projected to reach $2.8 billion in the following year, growing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include the discovery of hormones
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is